ExpertiseUpdated on 16 March 2026
Economic & Innovation Policy for Life Sciences
About
As Economic & Innovation Policy Lead at scienceindustries, I focus on designing and advancing framework conditions that enable innovation in Switzerland and internationally.
My work covers regulatory policy, international cooperation, and innovation ecosystems in the chemical, pharmaceutical, and life sciences industries. I engage with policymakers, industry leaders, and international partners to strengthen competitiveness, facilitate market access, and support resilient global value chains.
At the Global Innovation Summit, I offer insights into the Swiss policy landscape, opportunities for international collaboration, and perspectives on how regulatory and economic frameworks can accelerate innovation in biotech and beyond.
Field
- Biotech, Pharma and Cosmetics
Similar opportunities
Expertise
Oncology R&D leadership, translational strategy and platform building
- Biotech, Pharma and Cosmetics
Christoph Lampert
Vice President & Site Head | Biophamaceutical Executive at Xilis
Den Haag, Netherlands
Partnership
Robin Ribback
Funding Manager SRG / Head of Innovation Management / R&D at SRG
Bern, Switzerland
Expertise
Digitalisation Strategy: Bridging IT, OpEx, and Life Science Business
- Other
- Healthcare
- ICT Industry and Services
- Biotech, Pharma and Cosmetics
Michele Bruschi
Digitalisation Consultant | IT, OpEx & Business in Life Sciences
Basel, Switzerland